CVS Health Corp

CVS Health Corp(CVS)の株式分析

$92.580

+2.240 (+2.42%)終値時点

Loading chart…
高値
92.640
始値
91.780
出来高加重平均価格
92.07
出来高
14.27M
時価総額
73.26B
安値
91.000
売買代金
1.31B
EV/EBITDA(TTM)
8.38

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise.

cvshealth.com

AI分析 of CVS Health Corp (CVS)

中立

CVS Health Corp is currently trading at $86.16, which is below the average analyst price target of $110, indicating potential upside. However, the RSI is at 39.75, suggesting that the stock is in a bearish trend and may not be the best time to buy. Additionally, the forward P/E ratio is 10.67, which is attractive, but the recent news about Medicare Advantage ratings declining could impact future earnings. The main risk is the expected decline in adjusted EPS by $0.41 in 2028 due to these rating changes, which could pressure profitability.

バリュエーション指標

CVS Health Corp(CVS)の現在の予想PERは10.67で、5年平均は10.50です。

予想PER

適正
5年平均 P/E
10.50
現在のP/E
10.67
割高
12.11
割安
8.89

予想EV/EBITDA

適正
5年平均 EV/EBITDA
10.29
現在のEV/EBITDA
8.38
割高
14.76
割安
5.83

予想PSR

適正
5年平均 P/S
0.28
現在のP/S
0.26
割高
0.36
割安
0.20

Alphio AI による CVS の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%CVS

$66.08

シナリオ価格

基

基本

基本 · 50%CVS

$55.76

シナリオ価格

弱

弱気

弱気 · 25%CVS

$44.79

シナリオ価格

CVS を保有するクジラ

T

Turtle Creek Management, LLC

+ を保有CVS

+19.09%

3か月リターン

H

Hotchkis and Wiley Capital Management, LLC

+ を保有CVS

+8.90%

3か月リターン

N

Nan Shan Life Insurance Co., Ltd.

+ を保有CVS

+8.26%

3か月リターン

O

Osaic Advisory Services, LLC

+ を保有CVS

+6.98%

3か月リターン

G

GQG Partners, LLC

+ を保有CVS

+6.70%

3か月リターン

P

Pzena Investment Management, Inc.

+ を保有CVS

+6.68%

3か月リターン

CVS のよくある質問 — Alphio AI が回答

CVS Health Corporation is a health solutions company. The Company's segments include Health Care Benefits, Health Services, Pharmacy & Consumer Wellness and Corporate/Other. The Health Care Benefits segment offers a broad range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, PDPs and Medicaid health care management services. The Health Services segment provides a full range of pharmacy benefit management (PBM) solutions through its CVS Caremark operations and delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its CVS Pharmacy retail locations and, through its infusion operations, provides ancillary pharmacy services including pharmacy patient care programs, and vaccination administration, and sells a wide assortment of health and wellness products and general merchandise. It operates in the Healthcare sector (RETAIL-DRUG STORES AND PROPRIETARY STORES industry).

CVS Health Corp is currently trading at $86.16, which is below the average analyst price target of $110, indicating potential upside. However, the RSI is at 39.75, suggesting that the stock is in a bearish trend and may not be the best time to buy. Additionally, the forward P/E ratio is 10.67, which is attractive, but the recent news about Medicare Advantage ratings declining could impact future earnings. The main risk is the expected decline in adjusted EPS by $0.41 in 2028 due to these rating changes, which could pressure profitability.

コミュニティ

もっと見る ↗
0xSkewfalcon2026/10/5

PeloSwing Weekly Watchlist 👀 $CVS $PEP If you found this watchlist useful, make sure to turn notifications on for more! You don’t want to miss our posts throughout the day!🔔 Let’s have an amazing week! 💰

もっと見る
登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める